6.
Kim Y, Furuya H, Tabata Y
. Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels. Biomaterials. 2013; 35(1):214-24.
DOI: 10.1016/j.biomaterials.2013.09.103.
View
7.
Song Y, Wei J, Li R, Fu R, Han P, Wang H
. Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling. Hepatology. 2023; 78(5):1433-1447.
PMC: 10581422.
DOI: 10.1097/HEP.0000000000000319.
View
8.
Zhou Y, Zhang L, Ma Y, Xie L, Yang Y, Jin C
. Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma. Theranostics. 2023; 13(13):4430-4448.
PMC: 10465212.
DOI: 10.7150/thno.85369.
View
9.
Newick K, OBrien S, Moon E, Albelda S
. CAR T Cell Therapy for Solid Tumors. Annu Rev Med. 2016; 68:139-152.
DOI: 10.1146/annurev-med-062315-120245.
View
10.
Wrona E, Borowiec M, Potemski P
. CAR-NK Cells in the Treatment of Solid Tumors. Int J Mol Sci. 2021; 22(11).
PMC: 8197981.
DOI: 10.3390/ijms22115899.
View
11.
Guan L, Wu S, Zhu Q, He X, Li X, Song G
. GPC3-targeted CAR-M cells exhibit potent antitumor activity against hepatocellular carcinoma. Biochem Biophys Rep. 2024; 39:101741.
PMC: 11176667.
DOI: 10.1016/j.bbrep.2024.101741.
View
12.
Chen Y, Yu Z, Tan X, Jiang H, Xu Z, Fang Y
. CAR-macrophage: A new immunotherapy candidate against solid tumors. Biomed Pharmacother. 2021; 139:111605.
DOI: 10.1016/j.biopha.2021.111605.
View
13.
Huo Y, Zhang H, Sa L, Zheng W, He Y, Lyu H
. M1 polarization enhances the antitumor activity of chimeric antigen receptor macrophages in solid tumors. J Transl Med. 2023; 21(1):225.
PMC: 10044396.
DOI: 10.1186/s12967-023-04061-2.
View
14.
Zanoni M, Piccinini F, Arienti C, Zamagni A, Santi S, Polico R
. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci Rep. 2016; 6:19103.
PMC: 4707510.
DOI: 10.1038/srep19103.
View
15.
Dillard P, Koksal H, Inderberg E, Walchli S
. A Spheroid Killing Assay by CAR T Cells. J Vis Exp. 2019; (142).
DOI: 10.3791/58785.
View
16.
Morrissey M, Williamson A, Steinbach A, Roberts E, Kern N, Headley M
. Chimeric antigen receptors that trigger phagocytosis. Elife. 2018; 7.
PMC: 6008046.
DOI: 10.7554/eLife.36688.
View
17.
Klichinsky M, Ruella M, Shestova O, Lu X, Best A, Zeeman M
. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat Biotechnol. 2020; 38(8):947-953.
PMC: 7883632.
DOI: 10.1038/s41587-020-0462-y.
View
18.
June C, OConnor R, Kawalekar O, Ghassemi S, Milone M
. CAR T cell immunotherapy for human cancer. Science. 2018; 359(6382):1361-1365.
DOI: 10.1126/science.aar6711.
View
19.
Friedrich J, Seidel C, Ebner R, Kunz-Schughart L
. Spheroid-based drug screen: considerations and practical approach. Nat Protoc. 2009; 4(3):309-24.
DOI: 10.1038/nprot.2008.226.
View
20.
Daei Sorkhabi A, Mohamed Khosroshahi L, Sarkesh A, Mardi A, Aghebati-Maleki A, Aghebati-Maleki L
. The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies. Front Immunol. 2023; 14:1113882.
PMC: 10067596.
DOI: 10.3389/fimmu.2023.1113882.
View